These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33563114)
1. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis. Li J; Wang Y; Li J; Che G Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114 [TBL] [Abstract][Full Text] [Related]
2. High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis. Deng HY; Ma XS; Zhou J; Wang RL; Jiang R; Qiu XM Medicine (Baltimore); 2021 Apr; 100(15):e25447. PubMed ID: 33847650 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis. Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients. Zhu LR; Li J; Chen P; Jiang Q; Tang XP Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis. Wang Y; Wu Y; Li J; Li J; Che G Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153 [TBL] [Abstract][Full Text] [Related]
6. High pretreatment plasma D-dimer levels are associated with shorter overall survival in patients with small cell lung cancer. Fan S; Zhao G; An G J Int Med Res; 2019 Jan; 47(1):215-224. PubMed ID: 30270808 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis. Jin J; Yang L; Liu D; Li WM Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324 [TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis. Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis. Huang L; Shi Y Thorac Cancer; 2020 Nov; 11(11):3252-3259. PubMed ID: 32959954 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma D-dimer levels in patients with small-cell lung cancer. Chen Y; Yu H; Wu C; Li J; Jiao S; Hu Y; Tao H; Wu B; Li A Biomed Pharmacother; 2016 Jul; 81():210-217. PubMed ID: 27261596 [TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis. Lu Y; Jiang J; Ren C PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer. Zhang C; Jia Y; Jia Y; Zhang X; Li K Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis. Xie Y; Li H; Hu Y Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis. Li W; Tang Y; Song Y; Chen SH; Sisliyan N; Ni M; Zhang H; Zeng Q; Hou B; Xie X; Chang D Cell Physiol Biochem; 2018; 45(4):1663-1676. PubMed ID: 29490291 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer. Zhang Y; Cao J; Deng Y; Huang Y; Li R; Lin G; Dong M; Huang Z Clinics (Sao Paulo); 2020; 75():e993. PubMed ID: 32130355 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis. Tian Z; Liang C; Zhang Z; Wen H; Feng H; Ma Q; Liu D; Qiang G World J Surg Oncol; 2020 May; 18(1):116. PubMed ID: 32473655 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis. Wang Z; Wang Y; Zhang X; Zhang T Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620 [TBL] [Abstract][Full Text] [Related]
18. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis. Ma M; Cao R; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L J Cardiothorac Surg; 2021 Aug; 16(1):243. PubMed ID: 34454552 [TBL] [Abstract][Full Text] [Related]
19. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysis. Wu B; Zhang G; Zhao X; Wang J; Wang D; Zhang Y; Yu M; Cai H Asian J Surg; 2024 Aug; 47(8):3417-3424. PubMed ID: 38453610 [TBL] [Abstract][Full Text] [Related]
20. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer. Deng T; Zhang J; Meng Y; Zhou Y; Li W Medicine (Baltimore); 2018 Sep; 97(38):e12524. PubMed ID: 30235773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]